{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T02:52:53Z","timestamp":1716000773369},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,10,2]],"date-time":"2004-10-02T00:00:00Z","timestamp":1096675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1007\/s00259-004-1653-3","type":"journal-article","created":{"date-parts":[[2005,3,19]],"date-time":"2005-03-19T08:06:00Z","timestamp":1111219560000},"page":"274-285","source":"Crossref","is-referenced-by-count":29,"title":["Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell death"],"prefix":"10.1007","volume":"32","author":[{"given":"Christof","family":"Seidl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedwig","family":"Schr\ufffdck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Seidenschwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roswitha","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Abend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Friedrich","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Apostolidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuomo K.","family":"Nikula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Kremmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Schwaiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reingard","family":"Senekowitsch-Schmidtke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,10,2]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00262-002-0348-5","volume":"52","author":"DM Goldenberg","year":"2003","unstructured":"Goldenberg DM. Advancing role of radiolabeled antibodies in the therapy of cancer. Cancer Immunol Immunother 2003;52:281?96.","journal-title":"Cancer Immunol Immunother"},{"key":"CR2","first-page":"465","volume":"44","author":"GA Wiseman","year":"2003","unstructured":"Wiseman GA, Kornmehl E, Leigh B, Erwin WD, Podoloff DA, Spies S, et al. Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin?s lymphoma: combined data from 4 clinical trials. J Nucl Med 2003;44:465?74.","journal-title":"J Nucl Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1182\/blood.V98.3.565","volume":"78","author":"D Bunjes","year":"2001","unstructured":"Bunjes D, Buchmann I, Duncker C, Seitz C, Kotzerke J, Wiesneth M, et al. Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I?II study. Blood 2001;78:565?72.","journal-title":"Blood"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/cncr.10308","volume":"94","author":"TM Behr","year":"2002","unstructured":"Behr TM, Liersch T, Greiner-Bechert L, Griesinger F, Beh\u00e9 MP, Markus PM, et al. Radioimmunotherapy of small-volume disease of metastatic colorectal cancer: results of a phase II trial with the iodine-131-labeled humanized anti-carcinoembryonic antigen antibody hMN-14. Cancer 2002;94:1373?81.","journal-title":"Cancer"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00259-002-1050-8","volume":"30","author":"DJ Kwekkeboom","year":"2003","unstructured":"Kwekkeboom DJ, Bakker WH, Kam BL, Teunissen JJ, Kooij PPM, De Herder WW, et al. Treatment of patients with gastro-entero-pancreatic (GEP) tumors with the novel radiolabelled somatostatin analogue [177Lu-DOTA0, Tyr3]octreotate. Eur J Nucl Med Mol Imaging 2003;30:417?22.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2002.20.5.1389","volume":"20","author":"DA Reardon","year":"2002","unstructured":"Reardon DA, Akabani G, Coleman RE, Friedman AH, Friedman HS, Herndon JE, et al. Phase II trial of murine 131I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas. J Clin Oncol 2002;20:1389?97.","journal-title":"J Clin Oncol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/028418699431438","volume":"38","author":"P Riva","year":"1999","unstructured":"Riva P, Franceschi G, Frattarelli M, Riva N, Guiducci G, Cremonini AM, et al. 131I radioconjugated antibodies for the locoregional radioimmunotherapy of high-grade malignant glioma: phase I and II study. Acta Oncol 1999;38:351?9.","journal-title":"Acta Oncol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00259-002-1023-y","volume":"30","author":"L Bodei","year":"2003","unstructured":"Bodei L, Cremonesi M, Zoboli S, Grana C, Bartolomei M, Rocca P, et al. Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study. Eur J Nucl Med Mol Imaging 2003;30:207?16.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2307\/3578279","volume":"130","author":"RM Macklis","year":"1992","unstructured":"Macklis RM, Lin JY, Beresford B, Atcher RW, Hines JJ, Humm JL. Cellular kinetics, dosimetry, and radiobiology of ?-particle radioimmunotherapy: induction of apoptosis. Radiat Res 1992;130:220?6.","journal-title":"Radiat Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1182\/blood-2002-12-3867","volume":"101","author":"WA Bethge","year":"2003","unstructured":"Bethge WA, Wilbur DS, Storb R, Hamlin DK, Santos EB, Brechbiel MW, et al. Selective T-cell ablation with bismuth-213-labeled anti-TCR?? as nonmyeloablative conditioning for allogeneic canine marrow transplantation. Blood 2003;101:5068?75.","journal-title":"Blood"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1182\/blood-2002-01-0107","volume":"100","author":"M Zhang","year":"2002","unstructured":"Zhang M, Yao Z, Garmestani K, Axworthy DB, Zhang Z, Mallett RW, et al. Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the alpha-emitting radionuclide bismuth 213. Blood 2002;100:208?16.","journal-title":"Blood"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/cncr.10286","volume":"94","author":"S Supiot","year":"2002","unstructured":"Supiot S, Faivre-Chauvet A, Couturier O, Heymann MF, Robillard N, Kraeber-Bod\u00e9r\u00e9 F, et al. Comparison of the biological effects of MA5 and B-B4 monoclonal antibody labeled with iodine-131 and bismuth-213 on multiple myeloma. Cancer 2002;94:1202?9.","journal-title":"Cancer"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1126\/science.1064126","volume":"294","author":"MR McDevitt","year":"2001","unstructured":"McDevitt MR, Ma D, Lai LT, Simon J, Borchardt P, Frank RK, et al. Tumor therapy with targeted atomic nanogenerators. Science 2001;294:1537?40.","journal-title":"Science"},{"key":"CR14","first-page":"3914s","volume":"9","author":"H Andersson","year":"2003","unstructured":"Andersson H, Elgqvist J, Horvath G, Hultborn R, Jacobsson L, Jensen H, et al. Astatine-211-labeled antibodies for treatment of disseminated ovarian cancer: an overview of results in an ovarian tumor model. Clin Cancer Res 2003;9:3914s?21s.","journal-title":"Clin Cancer Res"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood.V100.4.1233.h81602001233_1233_1239","volume":"100","author":"JG Jurcic","year":"2002","unstructured":"Jurcic JG, Larson SM, Sgouros G, McDevitt MR, Finn RD, Divgi CR, et al. Targeted alpha particle immunotherapy for myeloid leukemia. Blood 2002;100:1233?9.","journal-title":"Blood"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2174\/1381612003399275","volume":"6","author":"MR Zalutsky","year":"2000","unstructured":"Zalutsky MR, Vaidyanathan G. Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy. Curr Pharm Des 2000;6:1433?55.","journal-title":"Curr Pharm Des"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D","volume":"12","author":"G Berx","year":"1998","unstructured":"Berx G, Becker K-F, H\u00f6fler H, van Roy F. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 1998;12:226?37.","journal-title":"Hum Mutat"},{"key":"CR18","first-page":"3845","volume":"54","author":"K-F Becker","year":"1994","unstructured":"Becker K-F, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, H\u00f6fler H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994;54:3845?52.","journal-title":"Cancer Res"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0002-9440(10)65497-1","volume":"155","author":"K-F Becker","year":"1999","unstructured":"Becker K-F, Kremmer E, Eulitz M, Becker I, Handschuh G, Schuhmacher C, et al. Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody. Am J Pathol 1999;155:1803?9.","journal-title":"Am J Pathol"},{"key":"CR20","first-page":"2804","volume":"61","author":"R Senekowitsch-Schmidtke","year":"2001","unstructured":"Senekowitsch-Schmidtke R, Schuhmacher C, Becker K-F, Nikula TK, Seidl C, Becker I, et al. Highly specific tumor binding of a 213Bi-labeled monoclonal antibody against mutant E-cadherin suggests its usefulness for locoregional ?-radioimmunotherapy of diffuse-type gastric cancer. Cancer Res 2001;61:2804?8.","journal-title":"Cancer Res"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1667\/0033-7587(2003)159[0612:COTROT]2.0.CO;2","volume":"159","author":"M Miederer","year":"2003","unstructured":"Miederer M, Seidl C, Beyer G-J, Charlton DE, Vranjes-Duric S, Comor JJ, et al. Comparison of the radiotoxicity of two alpha-particle-emitting immunoconjugates, terbium-149 and bismuth-213, directed against a tumor-specific, exon 9 deleted (d9) E-cadherin adhesion protein. Radiat Res 2003;159:612?20.","journal-title":"Radiat Res"},{"key":"CR22","first-page":"3922s","volume":"9","author":"R Huber","year":"2003","unstructured":"Huber R, Seidl C, Schmid E, Seidenschwang S, Becker K-F, Schuhmacher C, et al. Locoregional ?-radioimmunotherapy of intraperitoneal tumor cell dissemination using a tumor specific monoclonal antibody. Clin Cancer Res 2003;9:3922s?28s.","journal-title":"Clin Cancer Res"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/sj.cdd.4400419","volume":"5","author":"S Fulda","year":"1998","unstructured":"Fulda S, Scaffidi C, Pietsch T, Krammer PH, Peter ME, Debatin KM. Activation of the CD95 (APO-1\/Fas) pathway in drug- and gamma-irradiation-induced apoptosis of brain tumor cells. Cell Death Differ 1998;5:884?93.","journal-title":"Cell Death Differ"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00259-003-1216-z","volume":"30","author":"C Friesen","year":"2003","unstructured":"Friesen C, Lubatschofski A, Kotzerke J, Buchmann I, Reske SN, Debatin KM. Beta-irradiation used for systemic radioimmunotherapy induces apoptosis and activates apoptosis pathways in leukaemia cells. Eur J Nucl Med Mol Imaging 2003;30:1251?61.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/sj.bjc.6600179","volume":"86","author":"Y Li","year":"2002","unstructured":"Li Y, Rizvi SMA, Ranson M, Allen BJ. 213Bi-PAI conjugate selectively induces apoptosis in PC3 metastatic prostate cancer cell line and shows anti-cancer activity in a xenograft animal model. Br J Cancer 2002;86:1197?203.","journal-title":"Br J Cancer"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00259-003-1228-8","volume":"30","author":"K Vandenbuckle","year":"2003","unstructured":"Vandenbuckle K, De Vos F, Offner F, Philipp\u00e9 J, Apostolidis C, Molinet R, et al. In vitro evaluation of 213Bi-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and the chromosomal damage. Eur J Nucl Med Mol Imaging 2003;30:1357?64.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"CR27","first-page":"5815","volume":"53","author":"K Yanagihara","year":"1993","unstructured":"Yanagihara K, Ito A, Toge T, Numoto M. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 1993;53:5815?21.","journal-title":"Cancer Res"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/1097-0215(20001115)88:4<579::AID-IJC10>3.0.CO;2-U","volume":"88","author":"Y Fukudome","year":"2000","unstructured":"Fukudome Y, Yanagihara K, Takeichi M, Ito F, Shibamoto S. Characterization of a mutant E-cadherin protein encoded by a mutant gene frequently seen in diffuse-type human gastric carcinoma. Int J Cancer 2000;88:579?83.","journal-title":"Int J Cancer"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/path.1149","volume":"197","author":"K-F Becker","year":"2002","unstructured":"Becker K-F, Kremmer E, Eulitz M, Schulz S, Mages J, Handschuh G, et al. Functional allelic loss detected at the protein level in archival human tumours using allele-specific E-cadherin monoclonal antibodies. J Pathol 2002;197:567?74.","journal-title":"J Pathol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1021\/bc00001a007","volume":"1","author":"S Mirzadeh","year":"1990","unstructured":"Mirzadeh S, Brechbiel MW, Atcher RW, Gansow OA. Radiometal labeling of immunoproteins: covalent linkage of 2-(4-isothiocyanatobenzyl) diethylenetriaminepentaacetic acid ligands to immunoglobulin. Bioconjug Chem 1990;1:59?65.","journal-title":"Bioconjug Chem"},{"key":"CR31","first-page":"29","volume":"44","author":"C Apostolidis","year":"2001","unstructured":"Apostolidis C, Carlos-Marquez R, Janssens W, Molinet R, Nikula T, Ouadi A. Cancer treatment using Bi-213 and Ac-225 in radioimmunotherapy. Nucl News 2001;44:29?33.","journal-title":"Nucl News"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0022-1902(79)80423-6","volume":"14","author":"BY Spivakov","year":"1979","unstructured":"Spivakov BY, Stoyanov ES, Gribov LA, Zolotov YA. Raman laser spectroscopic studies of bismuth(III)halide complexes in aqueous solution. J Inorg Nucl Chem 1979;14:453?5.","journal-title":"J Inorg Nucl Chem"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0969-8051(94)00126-5","volume":"22","author":"TK Nikula","year":"1995","unstructured":"Nikula TK, Curcio MJ, Brechbiel MW, Gansow OA, Finn RD, Scheinberg DA. A rapid, single vessel method for preparation of clinical grade ligand conjugated antibodies. Nucl Med Biol 1995;22:387?90.","journal-title":"Nucl Med Biol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/095530000138907","volume":"76","author":"M Abend","year":"2000","unstructured":"Abend M, Kehe K, Kehe K, Riedel M, van Beuningen D. Correlation of micronucleus and apoptosis assays with reproductive cell death can be improved by considering other modes of death. Int J Radiat Biol 2000;76:249?59.","journal-title":"Int J Radiat Biol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1023\/A:1009697016510","volume":"5","author":"K Teramachi","year":"2000","unstructured":"Teramachi K, Izawa M. Rapid induction of apoptosis in human gastric cancer cell lines by sorbitol. Apoptosis 2000;5:181?7.","journal-title":"Apoptosis"},{"key":"CR36","first-page":"7709","volume":"6","author":"JC Mai","year":"2001","unstructured":"Mai JC, Mi Z, Kim SH, Ng B, Robbins PD. A proapoptotic peptide for the treatment of solid tumors. Cancer Res 2001;6:7709?12.","journal-title":"Cancer Res"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/mas.10066","volume":"23","author":"N Tang","year":"2004","unstructured":"Tang N, Tornatore P, Weinberger SR. Current developments in SELDI affinity technology. Mass Spectrom Rev 2004;23:34?44.","journal-title":"Mass Spectrom Rev"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1074\/mcp.M300033-MCP200","volume":"2","author":"C Melle","year":"2003","unstructured":"Melle C, Ernst G, Schimmel B, Bleul A, Koscielny S, Wiesner A, et al. Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip\u00ae technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry. Mol Cell Proteomics 2003;2:443?52.","journal-title":"Mol Cell Proteomics"},{"key":"CR39","first-page":"1868","volume":"62","author":"C Rosty","year":"2002","unstructured":"Rosty C, Christa L, Kuzdzal S, Baldwin WM, Zahurak ML, Carnot F, et al. Identification of hepatocarcinoma-intestine-pancreas\/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res 2002;62:1868?75.","journal-title":"Cancer Res"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"16850","DOI":"10.1074\/jbc.271.28.16850","volume":"271","author":"RC Armstrong","year":"1996","unstructured":"Armstrong RC, Aja T, Xiang J, Gaur S, Krebs JF, Hoang K, et al. Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J Biol Chem 1996;271:16850?5.","journal-title":"J Biol Chem"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1002\/j.1460-2075.1996.tb00598.x","volume":"15","author":"SJ Martin","year":"1996","unstructured":"Martin SJ, Amarante-Mendes GP, Shi L, Chuang TH, Casiano CA, O?Brien GA, et al. The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE\/CED-3 family protease, CPP32, via a novel two-step mechanism. EMBO J 1996;15:2407?16.","journal-title":"EMBO J"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2307\/3579935","volume":"151","author":"SJ Kennel","year":"1999","unstructured":"Kennel SJ, Stabin M, Roeske JC, Foote LJ, Lankford PK, Terzaghi-Howe M, et al. Radiotoxicity of bismuth-213 bound to membranes of monolayer and spheroid cultures of tumor cells. Radiat Res 1999;151:244?56.","journal-title":"Radiat Res"},{"key":"CR43","first-page":"1333","volume":"63","author":"ML Schipper","year":"2003","unstructured":"Schipper ML, Weber A, B\u00e9h\u00e9 M, G\u00f6ke R, Joba W, Schmidt H, et al. Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells. Cancer Res 2003;63:1333?8.","journal-title":"Cancer Res"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/bj3150021","volume":"315","author":"EA Slee","year":"1996","unstructured":"Slee EA, Zhu H, Chow SC, MacFarlane M, Nicholson DW, Cohen GM. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD-FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J 1996;315:21?4.","journal-title":"Biochem J"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/09553000310001596995","volume":"79","author":"A Holgersson","year":"2003","unstructured":"Holgersson A, Jernberg AR, Persson LM, Edgren MR, Lewensohn R, Nilsson A, et al. Low and high LET radiation-induced apoptosis in M059J and M059K cells. Int J Radiat Biol 2003;79:611?21.","journal-title":"Int J Radiat Biol"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/sj.cdd.4401296","volume":"10","author":"EC Bruin De","year":"2003","unstructured":"De Bruin EC, Meersma D, de Wilde J, den Otter I, Schipper EM, Medema JP, Peltenburg LTC. A serine protease is involved in the initiation of DNA damage-induced apoptosis. Cell Death Differ 2003;10:1204?12.","journal-title":"Cell Death Differ"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/sj.cdd.4401071","volume":"9","author":"H Zangger","year":"2002","unstructured":"Zangger H, Mottram JC, Fasel N. Cell death in Leishmania induced by stress and differentiation: programmed cell death or necrosis? Cell Death Differ 2002;9:1126?39.","journal-title":"Cell Death Differ"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.cdd.4401107","volume":"9","author":"CA Wilson","year":"2002","unstructured":"Wilson CA, Browning JL. Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis. Cell Death Differ 2002;9:1321?33.","journal-title":"Cell Death Differ"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s002590100484","volume":"28","author":"J-P Pouget","year":"2001","unstructured":"Pouget J-P, Mather SJ. General aspects of the cellular response to low- and high-LET radiation. Eur J Nucl Med 2001;28:541?61.","journal-title":"Eur J Nucl Med"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/09553000310001632958","volume":"79","author":"M Abend","year":"2003","unstructured":"Abend M. Reasons to reconsider the significance of apoptosis for cancer therapy. Int J Radiat Biol 2003;79:927?41.","journal-title":"Int J Radiat Biol"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/266653a0","volume":"266","author":"MA Ritter","year":"1977","unstructured":"Ritter MA, Cleaver JE, Tobias CA. High-LET radiations induce a large proportion of non-rejoining DNA breaks. Nature 1977;266:653?5.","journal-title":"Nature"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0360-3016(95)02112-4","volume":"34","author":"J Heilmann","year":"1996","unstructured":"Heilmann J, Taucher-Scholz G, Haberer T, Scholz M, Kraft G. Measurement of intracellular DNA double-strand break induction and rejoining along the track of carbon and neon particle beams in water. Int J Radiat Oncol 1996;34:599?608.","journal-title":"Int J Radiat Oncol"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrc992","volume":"3","author":"AV Gundkov","year":"2003","unstructured":"Gundkov AV, Komarova EA. The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer 2003;3:117?29.","journal-title":"Nat Rev Cancer"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1242\/jcs.114.23.4161","volume":"114","author":"J Rudner","year":"2001","unstructured":"Rudner J, Lepple-Wienhues A, Budach W, Berschauer J, Friedrich B, Wesselborg S, et al. Wild-type, mitochondrial and ER-restricted Bcl-2 inhibit DNA damage-induced apoptosis but do not affect death receptor-induced apoptosis. J Cell Sci 2001;114:4161?72.","journal-title":"J Cell Sci"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1093\/nar\/26.12.2859","volume":"26","author":"S Vispe","year":"1998","unstructured":"Vispe S, Cazaux C, Lesca C, Defais M. Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. Nucleic Acids Res 1998;26:2859?64.","journal-title":"Nucleic Acids Res"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-004-1653-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-004-1653-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-004-1653-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T01:25:15Z","timestamp":1625621115000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-004-1653-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,2]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["1653"],"URL":"https:\/\/doi.org\/10.1007\/s00259-004-1653-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,2]]}}}